Behind the microscope

Patrudu Makena

PhD in Genetic Toxicology, University of Memphis

Director, Non-Clinical Studies

A Better TomorrowTM is innovation of potentially reduced health impact products through robust science and technology.

Role at Reynolds

Favorite part of my job is finding solutions to challenges, learning new things from others, connecting with people, and always moving forward as a team.

Favorite part of your job?

Favorite part of my job is finding solutions to challenges, learning new things from others, connecting with people, and always moving forward as a team.

What does A Better TomorrowTM mean to you?

Innovation of potentially reduced health impact products through robust science and technology to expand choices for adult tobacco consumers and support our company’s tobacco harm reduction efforts.

Greatest career achievement (thus far)?

My greatest career achievement thus far as a scientist was being responsible for the development of biomarker research at Reynolds where I had an opportunity to work with prominent scientists in academia, industry, and within Reynolds. During this time, I drove several collaborative and novel projects including developing lung-on-a chip, real world evidence based predictive models, and adverse outcome pathways that resulted in many publications in respected journals.

Career timeline

2022-Present
Director, Non-Clinical Studies
RAI Services Company
2019 – 2022
Senior Manager, Clinical Science
RAI Services Company
2018 – 2019
Master Scientist, Product Integrity
RAI Services Company
2015 – 2018
Senior Staff Scientist, Biomarkers Research
RAI Services Company
2015 – 2015
Director of Preclinical Biology and Biomarker Studies
Rx.Bio. Inc

This website is owned and operated by RAI Services Company, an independent subsidiary of Reynolds American Inc. References to “Reynolds,” “the group,” “the company,” “we,” “us,” and “our” are simply for convenience and are not intended to imply or suggest that the subsidiaries’ businesses are operated other than as separate, distinct businesses.